This inventor holds 2 USPTO granted patents and 5 published patent applications and 2 EPO patents. Top assignee: Immusoft Corporation. Active years: 2019-2022.
Company Filing History:
Years Active: 2019-2022
Title: Mei Xu: Innovator in B Cell Differentiation
Introduction
Mei Xu is a prominent inventor based in Seattle, WA (US). She has made significant contributions to the field of biotechnology, particularly in the area of memory B cell differentiation. With a total of 2 patents, her work has the potential to impact therapeutic approaches in immunology.
Latest Patents
Mei Xu's latest patents include innovative methods for in vitro memory B cell differentiation and transduction with VSV-G pseudotyped viral vectors. These patents focus on the in vitro differentiation of memory B cells into plasmablasts or plasma cells. Additionally, they involve the genetic modification of these cells to express proteins of interest, such as specific antibodies or other therapeutic proteins.
Career Highlights
Mei Xu is currently associated with Immusoft Corporation, where she applies her expertise in biotechnology. Her work at the company emphasizes the development of advanced therapeutic solutions that leverage her patented methodologies.
Collaborations
Some of her notable coworkers include Matthew Rein Scholz and Eric J Herbig. Their collaboration contributes to the innovative environment at Immusoft Corporation, fostering advancements in the field.
Conclusion
Mei Xu's contributions to the field of biotechnology through her patents and work at Immusoft Corporation highlight her role as a leading inventor. Her innovative approaches to memory B cell differentiation are paving the way for future therapeutic developments.